GCG and obesity due to melanocortin 4 receptor deficiency: Preclinical and clinical studies demonstrate GLP-1 RAs’ cardioprotective effects, efficacy in hypertension and dyslipidemia, substantial weight loss in diabetes and obesity, and neuroprotective roles in stroke and neurodegenerative diseases.